Fig. 3.

Adjusted hazard ratio of various endocrine therapies on cardiovascular and cerebrovascular events. Hazard ratios for cardiovascular and cerebrovascular events in women older than 55 (n = 47,569, upper panel) or 60 (n = 30,024, lower panel) adjusted for hypertension, diabetes, age, body mass index, and family history (a). The adjusted risk of various endocrine therapies for subgroups of known risk factors are shown (b). ACS: acute coronary syndrome, IS: ischemic stroke, HS: hemorrhagic stroke.